Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...

HyperLight Corporation ("HyperLight"), creator of the TFLN Chiplet(TM) Platform, today announced the availability of 400G-per-lane thin-film lithium niobate (TFLN) photonic integrated circuits (PICs) ...

I Know Exactly How Much More Speed You Really Get With a Wi-Fi 7 Router ...

Accurate O2 measurement using laser technology in flare stacks enhances safety and compliance, preventing hazardous conditions in industrial plants.

HyperLight Corporation ("HyperLight"), creator of the TFLN Chiplet™ Platform, today announced the availability of ...

Accurately measuring small shifts in biological markers, like proteins and neurotransmitters, or harmful chemicals in the ...

This study presents a bionic robotic trunk that adapts stiffness rapidly, enhancing its ability to perform delicate tasks and support significant weight.

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice modulating ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...

A Consumer Research Report Examining Molecular Hydrogen Tablet Ingredients, Concentration Claims, and How Gundry MD Ultimate ...

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...